eISSN 2508-3589
pISSN 2508-1926
pISSN 2508-1926
Percentage of oil and air presence and number of silicone oil droplet in each group, according to the type of syringe
Group 1 (n = 10) | Group 2 (n = 10) |
|
Group 3 (n = 10) | Group 4 (n = 10) |
|
||
---|---|---|---|---|---|---|---|
Presence of oil | |||||||
Syringe 1 | 10 (100) | 5 (50) | 0.033 |
10 (100) | 1 (10) | < 0.001 |
|
Syringe 2 | 2 (20) | 0 | 0.474 |
1 (10) | 0 | 1.000 |
|
Syringe 3 | 8 (80) | 2 (20) | 0.023 |
5 (50) | 1 (10) | 0.141 |
|
Presence of air | |||||||
Syringe 1 | 2 (20) | 4 (40) | 0.628 |
4 (40) | 1 (10) | 0.303 |
|
Syringe 2 | 3 (30) | 1 (10) | 0.582 |
1 (10) | 1 (10) | 1.000 |
|
Syringe 3 | 5 (50) | 2 (20) | 0.350 |
4 (40) | 1 (10) | 0.303 |
|
Number of silicone oil droplets | |||||||
Syringe 1 | 11.7 ± 4.7 | 1.1 ± 1.4 | < 0.001 |
7.7 ± 3.5 | 0.3 ± 0.9 | < 0.001 |
|
Syringe 2 | 0.6 ± 1.4 | 0.0 ± 0.0 | 0.481 |
0.2 ± 0.6 | 0.0 ± 0.0 | 0.739 |
|
Syringe 3 | 2.2 ± 1.9 | 0.3 ± 0.7 | 0.009 |
1.3 ± 1.5 | 0.1 ± 0.3 | 0.089 |
Values are presented as mean ± standard deviation or number (%). Syringe 1 = Shinchang Medical Co.; Syringe 2 = Becton, Dickinson; Syringe 3 = Sungshim Medical Co.; Group 1 = bevacizumab with agitation; Group 2 = bevacizumab without agitation; Group 3 = fluid with agitation; Group 4 = fluid without agitation.
*Fisher’s exact test; †